[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO167569C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.

Info

Publication number
NO167569C
NO167569C NO864110A NO864110A NO167569C NO 167569 C NO167569 C NO 167569C NO 864110 A NO864110 A NO 864110A NO 864110 A NO864110 A NO 864110A NO 167569 C NO167569 C NO 167569C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically effective
analogy procedure
benzimidazold
derivatives
Prior art date
Application number
NO864110A
Other languages
English (en)
Other versions
NO167569B (no
NO864110L (no
NO864110D0 (no
Inventor
David Cox
David Edward Hall
Anthony Howard Ingall
John Louis Suschitzky
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858525454A external-priority patent/GB8525454D0/en
Priority claimed from GB858525452A external-priority patent/GB8525452D0/en
Priority claimed from GB868621768A external-priority patent/GB8621768D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of NO864110D0 publication Critical patent/NO864110D0/no
Publication of NO864110L publication Critical patent/NO864110L/no
Publication of NO167569B publication Critical patent/NO167569B/no
Publication of NO167569C publication Critical patent/NO167569C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO864110A 1985-10-16 1986-10-15 Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater. NO167569C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB858525454A GB8525454D0 (en) 1985-10-16 1985-10-16 Biologically active nitrogen heterocycles
GB858525452A GB8525452D0 (en) 1985-10-16 1985-10-16 Biologically active nitrogen heterocycles
GB868621768A GB8621768D0 (en) 1986-09-10 1986-09-10 N heterocyclic compounds

Publications (4)

Publication Number Publication Date
NO864110D0 NO864110D0 (no) 1986-10-15
NO864110L NO864110L (no) 1987-04-21
NO167569B NO167569B (no) 1991-08-12
NO167569C true NO167569C (no) 1991-11-20

Family

ID=27262821

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864110A NO167569C (no) 1985-10-16 1986-10-15 Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.

Country Status (9)

Country Link
US (1) US4851419A (no)
EP (1) EP0220053A3 (no)
KR (1) KR870003995A (no)
AU (1) AU599607B2 (no)
DK (1) DK493386A (no)
FI (1) FI864138A (no)
IL (1) IL80339A (no)
NO (1) NO167569C (no)
NZ (1) NZ217965A (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO1406B1 (en) * 1984-11-02 1986-11-30 سميث كلاين اند فرينش لابوراتوريز ليمتد Chemical compounds
US4824856A (en) * 1985-08-14 1989-04-25 Nippon Chemiphar Co., Ltd. Method of protecting gastrointestinal tract
KR870008853A (ko) * 1986-03-28 1987-10-21 오쯔까 아끼히꼬 하이드로퀴놀린 화합물의 제조방법
AU619444B2 (en) * 1986-06-02 1992-01-30 Nippon Chemiphar Co. Ltd. 2-(2-aminobenzylsulfinyl)- benzimidazole derivatives
JPH01501473A (ja) * 1986-09-27 1989-05-25 フアイソンズ・ピーエルシー 化合物
DE3722810A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung
AT389107B (de) * 1987-12-03 1989-10-25 Fisons Plc Neue benzimidazole, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
GB9115534D0 (en) * 1991-07-18 1991-09-04 Fisons Plc Compounds
ES2036948B1 (es) * 1991-11-21 1994-09-01 Genesis Para La Investigacion Procedimiento de obtencion de compuestos derivados de piridina.
KR0168978B1 (ko) * 1995-07-12 1999-01-15 김종인 헤테로고리 접합 티아졸 유도체
SE508669C2 (sv) * 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
US6583157B2 (en) 1998-01-29 2003-06-24 Tularik Inc. Quinolinyl and benzothiazolyl modulators
CA2318731C (en) * 1998-01-29 2012-05-29 Tularik Inc. Ppar-gamma modulators
US7041691B1 (en) * 1999-06-30 2006-05-09 Amgen Inc. Compounds for the modulation of PPARγ activity
US6653332B2 (en) 2000-05-03 2003-11-25 Tularik Inc. Combination therapeutic compositions and method of use
US20030171399A1 (en) * 2000-06-28 2003-09-11 Tularik Inc. Quinolinyl and benzothiazolyl modulators
US7718722B2 (en) * 2000-11-21 2010-05-18 Flexsys America L.P. Alkylthio- and aryl(heteroyl)thio-substituted p-phenylenediamines, their manufacture and their use in rubber
SE0104331D0 (sv) * 2001-12-19 2001-12-19 Astrazeneca Ab Novel compounds
US7223761B2 (en) 2003-10-03 2007-05-29 Amgen Inc. Salts and polymorphs of a potent antidiabetic compound
AU2005221140A1 (en) * 2004-03-08 2005-09-22 Amgen Inc. Therapeutic modulation of PPAR (gamma) activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CA1259070A (en) * 1983-07-01 1989-09-05 Upjohn Company (The) Substituted 2-¬monoannelated(3,4-,4,5-, and 5,6-)- pyridylalkylenesulfinyl|-benzimidazoles

Also Published As

Publication number Publication date
EP0220053A2 (en) 1987-04-29
NO167569B (no) 1991-08-12
US4851419A (en) 1989-07-25
IL80339A0 (en) 1987-01-30
FI864138A0 (fi) 1986-10-14
DK493386D0 (da) 1986-10-15
EP0220053A3 (en) 1988-02-10
FI864138A (fi) 1987-04-17
NZ217965A (en) 1990-09-26
NO864110L (no) 1987-04-21
DK493386A (da) 1987-04-17
AU6416986A (en) 1987-04-30
AU599607B2 (en) 1990-07-26
IL80339A (en) 1993-06-10
KR870003995A (ko) 1987-05-06
NO864110D0 (no) 1986-10-15

Similar Documents

Publication Publication Date Title
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO874764D0 (no) Fremgangsmaate for fremstilling av 2-aminopurinderivater.
NO864879D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiasolforbindelser.
NO167569C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
NO865013D0 (no) Fremgangsmaate for fremstilling av antibaktercelle kinolon-derivater.
NO159930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO864782D0 (no) Fremgangsmaate ved fremstilling av kinolon-derivater.
NO163453C (no) Fremgangsmaate for fremstilling av sphingosinderivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO164020C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.
NO165069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklopentyletere.
NO851920L (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater.
NO860429L (no) Fremgangsmaate for fremstilling av imidazolyl-indol-derivater.
NO156865B (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO164895C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO157736C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO162072C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater.
NO158063C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyrido-diazepin-derivater.
NO864818D0 (no) Fremgangsmaate for fremstilling av nye terapeutisk virksomme tetrahydroisokinolinderivater.
NO903397D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av protocatechualdehyd.
NO863769D0 (no) Fremgangsmaate for fremstilling av 4-hydroksy-2-oksopyrrolin-1-yl-acetamid.
NO166124C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzamidforbindelser.
NO162820C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolpyridin- eller benzimidazolderivater.
NO162020C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-indol-derivater.